Fatigue News and Research

RSS

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight immunotherapy advances being presented by researchers from The University of Texas MD Anderson Cancer Center at The Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting & Pre-Conference Programs.

11 Nov 2020

New study highlights the burden of post-COVID fatigue

More than half of people with acute COVID-19 infection continue to have persistent fatigue 10 weeks after their initial illness, according to a new study published November 9 in the open-access journal PLOS ONE by Liam Townsend of Trinity College Dublin, Ireland and colleagues.

11 Nov 2020

Study focuses on efficacy of cognitive rehabilitation across a range of neurological conditions

A new text by Kessler Foundation scientists focuses on the efficacy of cognitive rehabilitation across a variety of neurological conditions, with specific emphasis on treatment-related changes in the brain detectable via neuroimaging.

11 Nov 2020

Spit testing may aid non-invasive concussion diagnosis

Doctors may soon be able to more accurately diagnose concussions by measuring the number of certain molecules in a person's saliva, according to Penn State College of Medicine researchers.

9 Nov 2020

UT research enables intuitive human control of wearable robots to improve mobility of paretic patients

Wearable robots such as exoskeletons are often used in the rehabilitation of paretic patients (people with paralysis, for example after a stroke or spinal cord injury).

9 Nov 2020

Mymee's clinical trial demonstrates health-related quality of life improvements in lupus patients

Mymee Inc., the leading digital health company that empowers those who suffer from autoimmune disease to reclaim their health, today announced the publication of it’s study assessing the Mymee Program as adjunct care in patients with Systemic Lupus Erythematosus in the Journal of Medical Internet Research .

9 Nov 2020

ResMed launches new sleep education campaign

ResMed, a global leader in digital health and connected sleep and respiratory care devices, today announced the launch of a new sleep education campaign, #WakeUpToGoodSleep.

9 Nov 2020

Study: Hydroxychloroquine has no effect on abnormal heart rhythm in lupus patients with CKD

New research shows that adults with lupus who take the antimalarial drug, hydroxychloroquine, do not have any differences in their corrected QT (QTc) intervals, an electrocardiogram (EKG) measurement of the heart's electrical signals, even if they have chronic kidney disease (CKD), a complication of lupus that can be associated with increased levels of the medication.

9 Nov 2020

Researchers identify new strategy to combat loss of skeletal muscle mass

Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that stimulating expression of a protein naturally produced by the human body can be a strategy to combat loss of skeletal muscle mass, which happens normally with aging but can intensify in cases of neurodegenerative or inflammatory disease, or in patients who spend long periods in intensive care units (ICUs).

9 Nov 2020

Black patients with lupus have higher risk of stroke and ischemic heart disease

New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.

6 Nov 2020

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies.

6 Nov 2020

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global coronavirus pandemic, when antimalarials were touted as a possible COVID-19 treatment.

6 Nov 2020

VA joins Pentagon in recruiting volunteers for COVID vaccine trials

The Department of Veterans Affairs is recruiting 8,000 volunteers for the Phase 3 clinical trials of at least four COVID-19 vaccine candidates at 20 federal medical facilities across the U.S., according to officials with the VA and Operation Warp Speed, the Trump administration's initiative to fast-track a coronavirus vaccine.

6 Nov 2020

Chikungunya can infect central nervous system and impair cognitive, motor functions

A study conducted by an international team of researchers with FAPESP's support shows that infection by chikungunya virus can produce even more severe manifestations than the typical symptoms of the disease, such as acute fever, headache, rash, and intense joint and muscle pain.

4 Nov 2020

Fewer older adults may be experiencing restricting symptoms at the end of life

A new analysis published in the Journal of the American Geriatrics Society indicates that fewer older adults may be experiencing certain symptoms that can restrict their activity at the end of life.

4 Nov 2020

Study sheds light on possible lung damage caused by COVID-19 virus

The study, published today in The Lancet's eBioMedicine, by King's College London in collaboration with University of Trieste and the International Centre for Genetic Engineering and Biology in Italy, shows the unique characteristics to the SARS-CoV-2 virus and may explain why patients suffer from 'long COVID'.

4 Nov 2020

New study may help improve walking capacity in people with multiple sclerosis

Significant gaps in how walking capacity and performance is assessed for people with Multiple Sclerosis (MS) could be harming therapy and treatment development according to McGill University researchers.

3 Nov 2020

Study reveals seven “forms of disease” in COVID-19

In a study recently published in the top journal "Allergy", a team of MedUni Vienna scientists led by immunologist Winfried F. Pickl and allergologist Rudolf Valenta (both from the Center for Pathophysiology, Infectiology and Immunology) showed that there are seven "forms of disease" in COVID-19.

2 Nov 2020

Study shows compression garments reduce strength loss after strenuous exercise

Regular training enhances your strength, but recovery is equally important. Elastic bandages and compression garments are widely used in sports to facilitate recovery and prevent injuries.

30 Oct 2020

RNI researchers to study the impact of excessive speeds on the human brain, body

Before the first Virgin Hyperloop ride takes off, the brains behind pioneering neuroscience research at West Virginia University will help ensure the health and well-being of its passengers and operators.

30 Oct 2020

Fatigue News and Research

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

New study highlights the burden of post-COVID fatigue

Study focuses on efficacy of cognitive rehabilitation across a range of neurological conditions

Spit testing may aid non-invasive concussion diagnosis

UT research enables intuitive human control of wearable robots to improve mobility of paretic patients

Mymee's clinical trial demonstrates health-related quality of life improvements in lupus patients

ResMed launches new sleep education campaign

Study: Hydroxychloroquine has no effect on abnormal heart rhythm in lupus patients with CKD

Researchers identify new strategy to combat loss of skeletal muscle mass

Black patients with lupus have higher risk of stroke and ischemic heart disease

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

VA joins Pentagon in recruiting volunteers for COVID vaccine trials

Chikungunya can infect central nervous system and impair cognitive, motor functions

Fewer older adults may be experiencing restricting symptoms at the end of life

Study sheds light on possible lung damage caused by COVID-19 virus

New study may help improve walking capacity in people with multiple sclerosis

Study reveals seven “forms of disease” in COVID-19

Study shows compression garments reduce strength loss after strenuous exercise

RNI researchers to study the impact of excessive speeds on the human brain, body

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News